Skip to main content
Erschienen in: European Journal of Clinical Microbiology & Infectious Diseases 3/2018

06.02.2018 | Original Article

Diagnostic challenges in pyogenic spinal infection: an expanded role for FDG-PET/CT

verfasst von: Gannon J. Yu, Ingrid L. Koslowsky, Silvia A. Riccio, Angel K. M. Chu, Harvey R. Rabin, Reinhard Kloiber

Erschienen in: European Journal of Clinical Microbiology & Infectious Diseases | Ausgabe 3/2018

Einloggen, um Zugang zu erhalten

Abstract

In a preliminary investigation of FDG-PET/CT for assessment of therapy response of pyogenic spine infection, it was concluded that activity confined to the margins of a destroyed or degenerated joint with bone-on-bone contact represents nonseptic inflammation, regardless of the intensity of uptake. Only activity in bone, soft tissue, or within the epidural space represents active infection. The purpose of this investigation was to assess the performance of these pattern-based interpretation criteria in a series of problem cases of proven or suspected spine infection. Eighty-two FDG-PET/CTs were done for initial diagnosis because other imaging failed to provide a definitive diagnosis and 147 FDG-PET/CTs were done to assess treatment responses. Pattern-based interpretations were compared with the clinical diagnosis based on bacterial cultures and outcomes after cessation or withholding of antibiotic therapy. Pattern-based interpretation criteria achieved a sensitivity and specificity of 98 and 100%, respectively, for initial diagnosis and a specificity of 100% for assessment of treatment response. The same data was analyzed using intensity of activity as the primary factor. Sensitivity and specificity using the intensity-based criteria were 93 and 68%, respectively, for initial diagnosis, and the specificity of a negative interpretation for therapy response was 55%. Differences from pattern-based criteria are highly significant. Pattern-based criteria perform well in problem cases with equivocal MR and for treatment response because they correctly eliminate activity from nonspecific inflammation associated with destroyed joints with bone-on-bone contact. Response occurs within a timeframe that is useful for managing antibiotic therapy.
Literatur
1.
Zurück zum Zitat Berbari EF, Kanj SS, Kowalski TJ, Darouiche RO, Widmer AF, Schmitt SK, Hendershot EF, Holtom PD, Huddleston IIIPM, Petermann GW, Osmon DR (2015) 2015 Infectious Diseases Society of America (IDSA) clinical practice guidelines for the diagnosis and treatment of native vertebral osteomyelitis in adults. Clin Infect Dis 61(6):e26–e46CrossRefPubMed Berbari EF, Kanj SS, Kowalski TJ, Darouiche RO, Widmer AF, Schmitt SK, Hendershot EF, Holtom PD, Huddleston IIIPM, Petermann GW, Osmon DR (2015) 2015 Infectious Diseases Society of America (IDSA) clinical practice guidelines for the diagnosis and treatment of native vertebral osteomyelitis in adults. Clin Infect Dis 61(6):e26–e46CrossRefPubMed
2.
Zurück zum Zitat Siddiq DM, Musher DM, Darouiche RO (2014) Spinal and paraspinal pneumococcal infections-a review. Eur J Clin Microbiol Infect Dis 33(4):517–527CrossRefPubMed Siddiq DM, Musher DM, Darouiche RO (2014) Spinal and paraspinal pneumococcal infections-a review. Eur J Clin Microbiol Infect Dis 33(4):517–527CrossRefPubMed
3.
Zurück zum Zitat Colmenero JD, Jiménez-Mejías ME, Sánchez-Lora FJ, Reguera JM, Palomino-Nicás J, Martos F, García de las Heras J, Pachón J (1997) Pyogenic, tuberculous, and brucellar vertebral osteomyelitis: a descriptive and comparative study of 219 cases. Ann Rheum Dis 56(12):709–715CrossRefPubMedPubMedCentral Colmenero JD, Jiménez-Mejías ME, Sánchez-Lora FJ, Reguera JM, Palomino-Nicás J, Martos F, García de las Heras J, Pachón J (1997) Pyogenic, tuberculous, and brucellar vertebral osteomyelitis: a descriptive and comparative study of 219 cases. Ann Rheum Dis 56(12):709–715CrossRefPubMedPubMedCentral
4.
Zurück zum Zitat Mete B, Kurt C, Yilmaz MH, Ertan G, Ozaras R, Mert A, Tabak F, Ozturk R (2012) Vertebral osteomyelitis: eight years’ experience of 100 cases. Rheumatol Int 32(11):3591–3597CrossRefPubMed Mete B, Kurt C, Yilmaz MH, Ertan G, Ozaras R, Mert A, Tabak F, Ozturk R (2012) Vertebral osteomyelitis: eight years’ experience of 100 cases. Rheumatol Int 32(11):3591–3597CrossRefPubMed
5.
Zurück zum Zitat Perronne C, Saba J, Behloul Z, Salmon-Ceron D, Leport C, Vilde JL, Kahn MF (1994) Pyogenic and tuberculous spondylodiskitis (vertebral osteomyelitis) in 80 adult patients. Clin Infect Dis 19(4):746–750CrossRefPubMed Perronne C, Saba J, Behloul Z, Salmon-Ceron D, Leport C, Vilde JL, Kahn MF (1994) Pyogenic and tuberculous spondylodiskitis (vertebral osteomyelitis) in 80 adult patients. Clin Infect Dis 19(4):746–750CrossRefPubMed
7.
Zurück zum Zitat Jutte P, Lazzeri E, Sconfienza LM, Cassar-Pullicino V, Trampuz A, Petrosillo N, Signore A (2014) Diagnostic flowcharts in osteomyelitis, spondylodiscitis and prosthetic joint infection. Q J Nuclear Med Mol Imaging 58(1):2–19 Jutte P, Lazzeri E, Sconfienza LM, Cassar-Pullicino V, Trampuz A, Petrosillo N, Signore A (2014) Diagnostic flowcharts in osteomyelitis, spondylodiscitis and prosthetic joint infection. Q J Nuclear Med Mol Imaging 58(1):2–19
8.
Zurück zum Zitat Zarrouk V, Feydy A, Sallès F, Dufour V, Guigui P, Redondo A, Fantin B (2007) Imaging does not predict the clinical outcome of bacterial vertebral osteomyelitis. Rheumatology (Oxford, England) 46(2):292–295CrossRef Zarrouk V, Feydy A, Sallès F, Dufour V, Guigui P, Redondo A, Fantin B (2007) Imaging does not predict the clinical outcome of bacterial vertebral osteomyelitis. Rheumatology (Oxford, England) 46(2):292–295CrossRef
9.
Zurück zum Zitat Carragee E (1997) The clinical use of magnetic resonance imaging in pyogenic vertebral osteomyelitis. Spine (Phila Pa 1976) 22(7):780–785CrossRef Carragee E (1997) The clinical use of magnetic resonance imaging in pyogenic vertebral osteomyelitis. Spine (Phila Pa 1976) 22(7):780–785CrossRef
10.
Zurück zum Zitat Nanni C, Boriani L, Salvadori C, Zamparini E, Rorato G, Ambrosini V, Gasbarrini A, Tumietto F, Cristini F, Scudeller L, Boriani S, Viale P, Fanti S (2012) FDG PET/CT is useful for the interim evaluation of response to therapy in patients affected by haematogenous spondylodiscitis. Eur J Nucl Med Mol Imaging 39(10):1538–1544CrossRefPubMed Nanni C, Boriani L, Salvadori C, Zamparini E, Rorato G, Ambrosini V, Gasbarrini A, Tumietto F, Cristini F, Scudeller L, Boriani S, Viale P, Fanti S (2012) FDG PET/CT is useful for the interim evaluation of response to therapy in patients affected by haematogenous spondylodiscitis. Eur J Nucl Med Mol Imaging 39(10):1538–1544CrossRefPubMed
11.
Zurück zum Zitat Riccio SA, Chu AKM, Rabin HR, Kloiber R (2015) Fluorodeoxyglucose positron emission tomography/computed tomography interpretation criteria for assessment of antibiotic treatment response in pyogenic spine infection. Can Assoc Radiol J 66(2):145–152CrossRefPubMed Riccio SA, Chu AKM, Rabin HR, Kloiber R (2015) Fluorodeoxyglucose positron emission tomography/computed tomography interpretation criteria for assessment of antibiotic treatment response in pyogenic spine infection. Can Assoc Radiol J 66(2):145–152CrossRefPubMed
12.
Zurück zum Zitat Jamar F, Buscombe J, Chiti A, Christian PE, Delbeke D, Donohoe KJ, Israel O, Martin-Comin J, Signore A (2013) EANM/SNMMI guideline for 18F-FDG use in inflammation and infection. J Nucl Med 54(4):647–658CrossRefPubMed Jamar F, Buscombe J, Chiti A, Christian PE, Delbeke D, Donohoe KJ, Israel O, Martin-Comin J, Signore A (2013) EANM/SNMMI guideline for 18F-FDG use in inflammation and infection. J Nucl Med 54(4):647–658CrossRefPubMed
13.
Zurück zum Zitat Kumar R, Indrayan A (2011) Receiver operating characteristic (ROC) curve for medical researchers. Indian Pediatr 48(4):277–287CrossRefPubMed Kumar R, Indrayan A (2011) Receiver operating characteristic (ROC) curve for medical researchers. Indian Pediatr 48(4):277–287CrossRefPubMed
14.
Zurück zum Zitat Gemmel F, Rijk PC, Collins JMP, Parlevliet T, Stumpe KD, Palestro CJ (2010) Expanding role of 18F-fluoro-d-deoxyglucose PET and PET/CT in spinal infections. Eur Spine J 19(4):540–551CrossRefPubMedPubMedCentral Gemmel F, Rijk PC, Collins JMP, Parlevliet T, Stumpe KD, Palestro CJ (2010) Expanding role of 18F-fluoro-d-deoxyglucose PET and PET/CT in spinal infections. Eur Spine J 19(4):540–551CrossRefPubMedPubMedCentral
15.
Zurück zum Zitat Fuster D, Tomas X, Mayoral M, Soriano A, Manchon F, Cardenal C, Monegal A, Granados U, Garcia S, Pons F (2015) Prospective comparison of whole-body (18)F-FDG PET/CT and MRI of the spine in the diagnosis of haematogenous spondylodiscitis. Eur J Nucl Med Mol Imaging 42(2):264–271CrossRefPubMed Fuster D, Tomas X, Mayoral M, Soriano A, Manchon F, Cardenal C, Monegal A, Granados U, Garcia S, Pons F (2015) Prospective comparison of whole-body (18)F-FDG PET/CT and MRI of the spine in the diagnosis of haematogenous spondylodiscitis. Eur J Nucl Med Mol Imaging 42(2):264–271CrossRefPubMed
16.
Zurück zum Zitat Smids C, Kouijzer IJE, Vos FJ, Sprong T, Hosman AJF, de Rooy JWJ, Aarntzen EHJG, de Geus-Oei L-F, Oyen WJG, Bleeker-Rovers CP (2016) A comparison of the diagnostic value of MRI and 18F-FDG-PET/CT in suspected spondylodiscitis. Infection 45(1):41–49CrossRefPubMedPubMedCentral Smids C, Kouijzer IJE, Vos FJ, Sprong T, Hosman AJF, de Rooy JWJ, Aarntzen EHJG, de Geus-Oei L-F, Oyen WJG, Bleeker-Rovers CP (2016) A comparison of the diagnostic value of MRI and 18F-FDG-PET/CT in suspected spondylodiscitis. Infection 45(1):41–49CrossRefPubMedPubMedCentral
17.
Zurück zum Zitat Hartmann A, Eid K, Dora C, Trentz O, von Schulthess GK, Stumpe KDM (2007) Diagnostic value of 18F-FDG PET/CT in trauma patients with suspected chronic osteomyelitis. Eur J Nucl Med Mol Imaging 34(5):704–714CrossRefPubMed Hartmann A, Eid K, Dora C, Trentz O, von Schulthess GK, Stumpe KDM (2007) Diagnostic value of 18F-FDG PET/CT in trauma patients with suspected chronic osteomyelitis. Eur J Nucl Med Mol Imaging 34(5):704–714CrossRefPubMed
18.
Zurück zum Zitat Hungenbach S, Delank KS, Dietlein M, Eysel P, Drzezga A, Schmidt MC (2013) 18F-fluorodeoxyglucose uptake pattern in patients with suspected spondylodiscitis. Nucl Med Commun 34(11):1068–1074CrossRefPubMed Hungenbach S, Delank KS, Dietlein M, Eysel P, Drzezga A, Schmidt MC (2013) 18F-fluorodeoxyglucose uptake pattern in patients with suspected spondylodiscitis. Nucl Med Commun 34(11):1068–1074CrossRefPubMed
19.
Zurück zum Zitat Kouijzer IJE, Scheper H, de Rooy JWJ, Bloem JL, Janssen MJR, van den Hoven L, Hosman AJF, Visser LG, Oyen WJG, Bleeker-Rovers CP, de Geus-Oei LF (2017) The diagnostic value of 18F-FDG-PET/CT and MRI in suspected vertebral osteomyelitis - a prospective study. Eur J Nucl Med Mol Imaging. https://doi.org/10.1007/s00259-017-3912-0 PubMed Kouijzer IJE, Scheper H, de Rooy JWJ, Bloem JL, Janssen MJR, van den Hoven L, Hosman AJF, Visser LG, Oyen WJG, Bleeker-Rovers CP, de Geus-Oei LF (2017) The diagnostic value of 18F-FDG-PET/CT and MRI in suspected vertebral osteomyelitis - a prospective study. Eur J Nucl Med Mol Imaging. https://​doi.​org/​10.​1007/​s00259-017-3912-0 PubMed
20.
Zurück zum Zitat Love C, Palestro CJ (2016) Nuclear medicine imaging of bone infections. Clin Radiol 71(7):632–646CrossRefPubMed Love C, Palestro CJ (2016) Nuclear medicine imaging of bone infections. Clin Radiol 71(7):632–646CrossRefPubMed
21.
Zurück zum Zitat Rosen RS, Fayad L, Wahl RL (2006) Increased 18F-FDG uptake in degenerative disease of the spine: characterization with 18F-FDG PET/CT. J Nucl Med 47(8):1274–1280PubMed Rosen RS, Fayad L, Wahl RL (2006) Increased 18F-FDG uptake in degenerative disease of the spine: characterization with 18F-FDG PET/CT. J Nucl Med 47(8):1274–1280PubMed
22.
Zurück zum Zitat Kim S-JSJ, Kim I-J, Suh KT, Kim Y-K, Lee JS (2009) Prediction of residual disease of spine infection using F-18 FDG PET/CT. Spine (Philadelphia, Pa 1976) 34(22):2424–2430CrossRef Kim S-JSJ, Kim I-J, Suh KT, Kim Y-K, Lee JS (2009) Prediction of residual disease of spine infection using F-18 FDG PET/CT. Spine (Philadelphia, Pa 1976) 34(22):2424–2430CrossRef
23.
Zurück zum Zitat Niccoli Asabella A, Iuele F, Simone F, Fanelli M, Lavelli V, Ferrari C, Di Palo A, Notarisetefano A, Merenda NC, Rubini G (2015) Role of (18)F-FDG PET/CT in the evaluation of response to antibiotic therapy in patients affected by infectious spondylodiscitis. Hellenic J Nuclear Med 18(Suppl 1):17–22 Niccoli Asabella A, Iuele F, Simone F, Fanelli M, Lavelli V, Ferrari C, Di Palo A, Notarisetefano A, Merenda NC, Rubini G (2015) Role of (18)F-FDG PET/CT in the evaluation of response to antibiotic therapy in patients affected by infectious spondylodiscitis. Hellenic J Nuclear Med 18(Suppl 1):17–22
Metadaten
Titel
Diagnostic challenges in pyogenic spinal infection: an expanded role for FDG-PET/CT
verfasst von
Gannon J. Yu
Ingrid L. Koslowsky
Silvia A. Riccio
Angel K. M. Chu
Harvey R. Rabin
Reinhard Kloiber
Publikationsdatum
06.02.2018
Verlag
Springer Berlin Heidelberg
Erschienen in
European Journal of Clinical Microbiology & Infectious Diseases / Ausgabe 3/2018
Print ISSN: 0934-9723
Elektronische ISSN: 1435-4373
DOI
https://doi.org/10.1007/s10096-018-3197-7

Weitere Artikel der Ausgabe 3/2018

European Journal of Clinical Microbiology & Infectious Diseases 3/2018 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

„Jeder Fall von plötzlichem Tod muss obduziert werden!“

17.05.2024 Plötzlicher Herztod Nachrichten

Ein signifikanter Anteil der Fälle von plötzlichem Herztod ist genetisch bedingt. Um ihre Verwandten vor diesem Schicksal zu bewahren, sollten jüngere Personen, die plötzlich unerwartet versterben, ausnahmslos einer Autopsie unterzogen werden.

Herzinfarkt mit 85 – trotzdem noch intensive Lipidsenkung?

16.05.2024 Hypercholesterinämie Nachrichten

Profitieren nach einem akuten Myokardinfarkt auch Betroffene über 80 Jahre noch von einer intensiven Lipidsenkung zur Sekundärprävention? Um diese Frage zu beantworten, wurden jetzt Registerdaten aus Frankreich ausgewertet.

ADHS-Medikation erhöht das kardiovaskuläre Risiko

16.05.2024 Herzinsuffizienz Nachrichten

Erwachsene, die Medikamente gegen das Aufmerksamkeitsdefizit-Hyperaktivitätssyndrom einnehmen, laufen offenbar erhöhte Gefahr, an Herzschwäche zu erkranken oder einen Schlaganfall zu erleiden. Es scheint eine Dosis-Wirkungs-Beziehung zu bestehen.

Bei Herzinsuffizienz muss „Eisenmangel“ neu definiert werden!

16.05.2024 Herzinsuffizienz Nachrichten

Bei chronischer Herzinsuffizienz macht es einem internationalen Expertenteam zufolge wenig Sinn, die Diagnose „Eisenmangel“ am Serumferritin festzumachen. Das Team schlägt vor, sich lieber an die Transferrinsättigung zu halten.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.